TP Therapeutics Funding & Investors
Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves medical sector in the United States.
tptherapeutics.comTotal Amount Raised: $125,000,000
TP Therapeutics Funding Rounds
Private Equity
$80,000,000
Private Equity Investors
Foresite CapitalvenBio PartnersHBM Healthcare InvestmentsSr OneNextech InvestCormorant Asset ManagementLilly Asia VenturesKenson VenturesOrbiMedSeries C
$45,000,000
Series C Investors
Lilly Asia VenturesOrbiMedSr OneCormorant Asset ManagementSV Tech Ventures
Funding info provided by Diffbot.